Alloy Therapeutics empowers scientists with access to pre-competitive biologics drug discovery technologies and services across six modalities.

Altos’ mission is to restore cell health and resilience through cell rejuvenation to reverse disease, injury and the disabilities that can occur throughout life.

Almost one million people are living with dementia today. Tragically, not one of them will survive.  Alzheimer’s Research UK, the UK’s leading dementia research charity, exists to change that. The charity’s mission is to accelerate progress towards a cure for dementia by revolutionising the way it is treated, diagnosed, and prevented.

Amphista is identifying and advancing novel approaches in targeted protein degradation (TPD) to develop a new generation of innovative therapies.

Bicycle is developing precision-guided therapeutics, to penetrate deep into tissues and target intractable cancers.

Cancer Research UK is the world's largest independent cancer research organisation. It funds scientists, doctors and nurses to help beat cancer sooner and provides cancer information to the public.

Gilead focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.

Nxera’s mission is to accelerate the development of life-changing medicines by investing in science and technology.

Sphere Bio specialises in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, analysis and isolation.

Thermo Fisher Scientific is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services.

TWI is one of the world’s foremost independent research and technology organisations, with expertise in materials joining and engineering processes.

Vernalis Research develops and applies fragment and structure-based methods to drug discovery, and has generated cell active lead compounds and development candidates against biological targets in oncology, neurodegeneration, anti-infectives and inflammation.

T-Therapeutics was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.

Syngenta is a world leading life sciences company, applying unrivalled scientific expertise, knowledge, and capability through a range of advanced products and technologies to support sustainable agricultural practices globally.  By investing in cutting-edge research, fostering collaborations, and developing sustainable solutions, Syngenta is helping to secure the UK's future as a hub of scientific excellence and innovation for agricultural life sciences.

In the UK we employ 2500 people in life science research, advanced manufacturing, market deployment and enabling roles across eight sites.